scPharmaceuticals Inc

NASDAQ:SCPH   3:59:59 PM EDT
8.90
-0.15 (-1.66%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

scPharmaceuticals Inc. Stock, NASDAQ:SCPH

2400 DISTRICT AVENUE, SUITE 310, BURLINGTON, MA 01803
United States of America
Phone: 617-517-0730
Number of Employees: 21

Description

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is Furoscix that consists of proprietary buffered formulation of furosemide, which is delivered through the SmartDose drug delivery system for treatment of congestion in decompensated heart failure patients. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. to incorporate SmartDose drug delivery system with Furoscix. The company was founded in 2013 and is headquartered in Burlington, Massachusetts.